Masimo study finds SET pulse oximetry accurate across newborn skin tones

• Masimo disclosed results from NeoPODS, a prospective NICU study of its SET pulse oximetry in hospitalized newborns, with findings already presented at Pediatric Academic Societies meeting on April 27.
• Study reported monitoring performance remained accurate across skin tones, with no clinically meaningful differences tied to pigmentation or race.
• Researchers observed no occult hypoxemia among Black or Hispanic newborns, supporting Masimo’s positioning on equitable performance in high-acuity settings.
• Masimo highlighted earlier INSPIRE feasibility results in critically ill adults, with full INSPIRE study results expected later this year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Masimo Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202604280800BIZWIRE_USPR_____20260428_BW136753) on April 28, 2026, and is solely responsible for the information contained therein.